100
Participants
Start Date
November 8, 2024
Primary Completion Date
November 30, 2034
Study Completion Date
November 30, 2034
Clinical Research Centre for Rare Diseases Aldo e Cele Daccò, Ranica
Mario Negri Institute for Pharmacological Research
OTHER